ImmunoGen, Inc. (NASDAQ:IMGN) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to ImmunoGen’s second quarter 2023 financial and operating results conference call. Today’s conference is being recorded.
Source: insidermonkey.com
Page 4 - Mark Enyedy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Enyedy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Enyedy Today - Breaking & Trending Today
ImmunoGen Announces Departure of Anna Berkenblit, Chief Medical Officer
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Anna Berkenblit, MD, Senior Vice President and Chief Medical Officer,...
Source: marketscreener.com
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare Conference
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Mark Enyedy, President and CEO, and Anna Berkenblit, Chief Medical... | June 11, 2023
Source: marketscreener.com
Stock Market | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Resul
ELAHERE® Demonstrates Overall Survival Benefit in the Phase 3 MIRASOL Trial in Patients with FRα-Positive Platinum-Resistant Ovarian Cancer Results Show Statistically Significant Improvements in PFS, ORR, and OS Compared to Chemotherapy First Medicine to Demonstrate an Overall Survival Adv...
Source: pharmiweb.com